Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Simple computer alert could curb antibiotic overuse in hospitals

NCT ID NCT07115966

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This trial tests whether a simple computer alert can help doctors use antibiotics more wisely. The alert reminds prescribers to review antibiotic treatment after 72 hours (or 24 hours for surgery prevention) to see if they can stop or switch to a more targeted drug. The study involves 58 hospital wards and compares antibiotic use before and after the alert is introduced. The goal is to reduce both the amount and the breadth of antibiotics used, which could help fight antibiotic resistance.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
computer alert system
What this could lead to
If it works, this could provide a simple, low-cost way to reduce unnecessary antibiotic use in hospitals, helping fight antibiotic resistance.
What could go wrong
This is a small, early-stage trial in one hospital system. The alert may not change doctor behavior or may lead to unintended consequences like delayed treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 58 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: • All inpatient wards with at least 50 PA/year, except those listed in the exclusion criteria Exclusion Criteria: Ward level: * Emergency departments * Outpatient clinics * Haemato-oncologic stem cell transplant wards, where daily ID visits are performed * ICU wards, where daily ID visits are performed Indvidual patient data for analysis • Refusal of institutional general consent for further use of patient data

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Antibiotic prescriptions are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Inselgruppe

    Bern, 3007, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.